Noticias

Noticias

  • Título: Chinese FDA approves Straub Endovascular System
  • Fecha: 07-01-2015
  • Wangs (Switzerland), January 7th, 2015 – Straub Medical AG announced today that the Chinese FDA has approved the Straub Endovascular System with its Rotarex®S and Aspirex®S rotational catheter families. These endovascular rotational catheters restore blood flow in occluded blood vessels by removing occlusion material from the vessel. Specialized medical professionals such as vascular surgeons, interventional radiologists and other endovascular specialists use this technology during minimally invasive procedures known as endovascular interventions.

    Professor LIU Changwei, VP of the Chinese Society of Vascular Surgery, Director of the Vascular Surgery Center at Chinese Academy of Medical Sciences and Peking Union Medical College Hospital, commented: “The CFDA approval of Rotarex®S and Aspirex®S catheters will bring the Chinese physicians an internationally accepted, innovative and effective solution to address the challenges of arterial and venous occlusive diseases. We look forward to using the new system soon and deliver advanced and more efficient endovascular therapies to our patients.”

    Straub Medical AG has mandated Shanghai Micro Medical Devices Co. Ltd. with distribution and service of its products in China. Tony Liu, President & CEO of SMM, welcomes this addition to their portfolio: “We aim to supply a comprehensive portfolio of products and services to vascular specialists in all regions of China, and to provide a total solution for interventions. Rotarex®S and Aspirex®S perfectly match with our promise to provide interventionists with the tools they need to effectively help their patients.”

    About Straub Medical AG
    Straub Medical AG develops and manufactures medical devices for the treatment of vascular disease and markets its products in more than 40 countries worldwide. Founded in 1997, Straub Medical AG operates as a family-held private corporation. The company is headquartered in Wangs, canton Sankt Gallen, Switzerland.

    Related weblinks:
    www.straubmedical.com
    www.shmicro.com

    Media contact for this release:
    Straub Medical AG
    Christian Vetter
    Product Management & Marketing International
    Phone: +41 81 720 04 60
    christian.vetter@straubmedical.com



  • Fuente: endovascular.es